![](/img/cover-not-exists.png)
Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeksâA proof-of-concept study
Kahlert, C. R., Cipriani, M., Vernazza, P., De Socio, Giuseppe VittorioVolume:
15
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0237770
Date:
September, 2020
File:
PDF, 1.01 MB
2020